Development of a robust real-world data platform for rare diseases

We use the example of chronic demyelinating polyneuropathy (CIDP) to demonstrate the utility of AllStripes’ rare disease real-world data (RWD) platform in assessing natural history, health-care utilization and outcomes. This poster was presented at the International Society for Pharmacoepidemiology (ISPE) 36th International Conference on Pharmacoepidemiology & Therapeutic Risk Management in September 2020.